ideology-health
  • Our Solutions
  • About Us
  • ideology-health
    Privacy Policy
    Terms of Service
    Inc. 5000

    IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

    © 2026 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.

    W

    Dr Wade Iams, MD

    Medical professional dedicated to sharing knowledge and insights through educational videos.

    Dr. Wade Iams reviews the efficacy of dose interruption/reduction strategies for patients with EGFRm mNSCLC on 1L amivantamab + lazertinib (Video 2/3)

    Dr. Wade Iams reviews the efficacy of dose interruption/reduction strategies for patients with EGFRm mNSCLC on 1L amivantamab + lazertinib (Video 2/3)

    MARIPOSA dose interruption/reduction efficacy

    Wade Iams, MD
    Lung Cancer
    Dr. Wade Iams discusses adverse event prophylaxis strategies for patients with EGFRm mNSCLC on 1L amivantamab subQ + lazertinib (Video 1/3)

    Dr. Wade Iams discusses adverse event prophylaxis strategies for patients with EGFRm mNSCLC on 1L amivantamab subQ + lazertinib (Video 1/3)

    COPERNICUS Design, Efficacy

    Wade Iams, MD
    Lung Cancer
    Dr. Wade Iams shares his insights on connecting actionable mutations to therapy in lung cancer (Video 3/3)

    Dr. Wade Iams shares his insights on connecting actionable mutations to therapy in lung cancer (Video 3/3)

    PM in Lung – matching therapy to mutation

    Wade Iams, MD
    Lung Cancer
    Dr. Wade Iams shares his insights on reading an NGS report in lung cancer (Video 2/3)

    Dr. Wade Iams shares his insights on reading an NGS report in lung cancer (Video 2/3)

    Reading an NGS report

    Wade Iams, MD
    Lung Cancer
    Dr. Wade Iams shares his insights on liquid and tissue-based NGS testing in lung cancer (Video 1/3)

    Dr. Wade Iams shares his insights on liquid and tissue-based NGS testing in lung cancer (Video 1/3)

    Liquid NGS background

    Wade Iams, MD
    Lung Cancer